Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome. - Wikidata - wikimedia - TriplyDB

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

http://www.wikidata.org/entity/Q37382191

about

Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling.Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.Recent advances in proteasome inhibitor discovery.Proteasome inhibitor patents (2010 - present).Novel metals and metal complexes as platforms for cancer therapy Inhibition of the purified 20S proteasome by non-heme iron complexes.Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome.Copper and its complexes in medicine: a biochemical approach.Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone.Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression.

P2860

Q33884616-13BB676F-CCAD-4AD9-9A20-11DF8F8B56C3 Q34169479-4B54C695-0829-4C31-9EBC-C85D0D990A4D Q34195083-19C34F0D-22E3-44A9-8B81-8478196E8161 Q34645067-6CBB0D98-FF02-4A91-9F15-184ED220909F Q35085938-E3F3ED11-5246-4FCD-AE03-E3BB63A9CD48 Q37137649-15C279B1-F3AC-4AE9-96F4-510EA07029ED Q37217564-C0552C6C-66B0-45A7-AA52-6B7B4F7DE32A Q37304068-0C174C88-C0FE-4E97-981A-00022832B2BD Q38730238-215C93F9-A88D-445C-9C8D-B805330D2483 Q39022882-DF8A92D7-5774-44C5-B47B-BE96D7C9BAE8 Q39490260-38A9B790-B314-49E8-A0BA-0E844C10A761 Q47631097-D865940D-6D87-4616-99B8-851C5F329FCE Q54379435-497A8201-92B2-4725-B29E-70F04BD082A3

P2860

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

http://www.wikidata.org/entity/Q37382191

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metals in anticancer therapy: copper

@nl

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

@en

type

label

Metals in anticancer therapy: copper

@nl

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

@en

prefLabel

Metals in anticancer therapy: copper

@nl

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

@en

P1433

Q37382191-275AF1DA-E49E-4D86-BD2F-944C5F68EBFE

P1476

Q37382191-6070A330-C331-404E-A7F5-4C83EA09846C

P2093

Q37382191-2CDA34A7-D088-44DC-9EC3-99558CFECB72

Q37382191-5BBB779A-F1B6-4E29-AC96-500CD81D6EA0

Q37382191-6E24E1D3-2450-4C81-B6C3-CEFF9F619E94

Q37382191-78EC8E4A-F254-48B7-86CB-F1660B781EF4

Q37382191-96E97687-F466-4531-8238-1E3B412F7F17

Q37382191-99469559-7964-4260-A015-F6F033959FC4

Q37382191-C7B5E31E-4985-4A8C-804B-80362F7C3F6E

Q37382191-EF46A90F-EA16-496D-B926-6DB921872327

P2860

Q37382191-037EC3EE-B939-4822-B374-2DE6CB8FD83B

Q37382191-0394B350-E9A4-4BE7-A881-6655F538650F

Q37382191-090C6768-1CE4-4A2F-BFBB-97D127BF7731

Q37382191-0DF6A470-B7C5-4EBB-8502-D378530A237E

Q37382191-12A0415D-21B0-44DC-9741-BDBC8E668036

Q37382191-12B63EE2-F739-4CBD-88DF-28AF7919584A

Q37382191-179A87CA-4286-4A0F-A772-529171CAAE62

Q37382191-1ECB66FF-E899-4604-A1D8-3D7A39708889

Q37382191-231B42BD-7F49-4417-BFA2-1A4EFB63B67B

Q37382191-2C94AFA6-C8C6-488A-8509-F9E454164A9A

P304

Q37382191-19DD85C6-FAAB-4DE7-A63E-5387328C01D2

P31

Q37382191-74B880D1-C3E2-4FC6-B6BE-2E56F743CCFC

P356

Q37382191-FFDA0EF3-16E2-48D4-8C30-38C9E6BDAD0D

P433

Q37382191-9D84A4A1-29AC-4C69-81C4-96C1997A1778

P478

Q37382191-5A494CD3-2F24-4FF7-9307-54113E2130A5

P577

Q37382191-977AFB2B-BFFA-4A96-93A4-934FD8B28AAE

P5875

Q37382191-77B08DAB-00CD-499E-BBD8-CFA59B5BA6C6

P698

Q37382191-56D3BC1E-E556-4AFA-9909-0B570CA44F8E

P932

Q37382191-E3327930-2EF0-46E2-B8AE-1B5BA5AB8204

P356

J.EJMECH.2009.05.019

P1433

European Journal of Medicinal Chemistry

P1476

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

@en

P2093

Bruce R McGarvey

http://www.w3.org/2001/XMLSchema#string

Cláudio N Verani

http://www.w3.org/2001/XMLSchema#string

Dajena Tomco

http://www.w3.org/2001/XMLSchema#string

Lew Hryhorczuk

http://www.w3.org/2001/XMLSchema#string

Mary Jane Heeg

http://www.w3.org/2001/XMLSchema#string

Michael Frezza

http://www.w3.org/2001/XMLSchema#string

Q Ping Dou

http://www.w3.org/2001/XMLSchema#string

Sarmad Sahiel Hindo

http://www.w3.org/2001/XMLSchema#string

P2860

Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.

Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Proteasome inhibitors as potential novel anticancer agents.

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease.

The resurgence of platinum-based cancer chemotherapy.

Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.

New metal complexes as potential therapeutics.

Proteasome inhibition as a novel therapeutic target in human cancer.

P304

4353-4361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJMECH.2009.05.019

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26323731

http://www.w3.org/2001/XMLSchema#string

P698

19559507

http://www.w3.org/2001/XMLSchema#string

P932

2759842

http://www.w3.org/2001/XMLSchema#string